624 results on '"Sester, Martina"'
Search Results
2. Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients
3. Tuberculosis prevention: current strategies and future directions
4. Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin
5. Time-resolved RNA signatures of CD4+ T cells in Parkinson’s disease
6. Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel
7. Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
8. Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination
9. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis
10. The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in dialysis patients
11. Cholesteatoma, immunology and gender medicine
12. Cholesteatome, Immunologie und geschlechtssensible Medizin
13. NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens
14. Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination
15. Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
16. Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis
17. Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form
18. Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
19. Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
20. Impact of COVID-19 in solid organ transplant recipients
21. Elite athletes on regular training show more pronounced induction of vaccine-specific T-cells and antibodies after tetravalent influenza vaccination than controls
22. Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
23. Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL‐17 expression associated with cancer relapse
24. Tuberculosis prevention: current strategies and future directions
25. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
26. Assigning Cytomegalovirus Status in Children Awaiting Organ Transplant : Viral Shedding, CMV-Specific T Cells, and CD27⁻CD28⁻CD4⁺ T Cells
27. Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
28. CMV-specific T-cells and CD27-CD28-CD4+ T-cells for assignment of cytomegalovirus (CMV) status in adults awaiting organ transplant
29. Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL‐17 expression associated with cancer relapse.
30. Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin
31. Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients with and without history of SARS-CoV-2 infection
32. A novel Rift Valley fever vaccine
33. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation
34. Quantitative, Phenotypical, and Functional Characterization of Cellular Immunity in Children and Adolescents With Down Syndrome
35. Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis
36. SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals
37. Evaluation of antigen specific interleukin-1β as a biomarker to detect cattle infected with Mycobacterium bovis
38. High-dose intranasal application of titanium dioxide nanoparticles induces the systemic uptakes and allergic airway inflammation in asthmatic mice
39. Novel human sex-typing strategies based on the autism candidate gene NLGN4X and its male-specific gametologue NLGN4Y
40. Tuberculosis in immunocompromised patients
41. Timing of Vaccination after Training: Immune Response and Side Effects in Athletes
42. IgG4 serum levels are not elevated in cases of Post-COVID syndrome
43. Transient Positive SARS-CoV-2 PCR without Induction of Systemic Immune Responses
44. Differences in SARS-CoV-2 Specific Humoral and Cellular Immune Responses after Contralateral and Ipsilateral COVID-19 Vaccination
45. Activation of Transcription Factor NF-κB by the Adenovirus E3/19K Protein Requires Its ER Retention
46. Development of an improved ESAT-6 and CFP-10 peptide-based cytokine flow cytometric assay for bovine tuberculosis
47. miR-34a as hub of T cell regulation networks
48. miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling
49. Altered Phenotype and Functionality of Varicella Zoster Virus-Specific Cellular Immunity in Individuals With Active Infection
50. Scattered pustular lesions 10 days after Shingrix vaccination in systemic sclerosis patient after successful autologous non-myeloablative haemopoietic stem-cell transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.